{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T16:48:30Z","timestamp":1791996510528,"version":"4.4.0"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100009447","name":"Leukemia and Lymphoma Society of Canada","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100009447","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000015","name":"Canadian Cancer Society Research Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000015","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytokine"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1016\/j.cyto.2015.12.025","type":"journal-article","created":{"date-parts":[[2016,1,23]],"date-time":"2016-01-23T08:31:00Z","timestamp":1453537860000},"page":"52-57","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":85,"special_numbering":"C","title":["TC-PTP and PTP1B: Regulating JAK\u2013STAT signaling, controlling lymphoid malignancies"],"prefix":"10.1016","volume":"82","author":[{"given":"Kelly A.","family":"Pike","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel L.","family":"Tremblay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cyto.2015.12.025_b0005","doi-asserted-by":"crossref","first-page":"3899","DOI":"10.1182\/blood-2013-08-460311","article-title":"Genome sequencing of lymphoid malignancies","volume":"122","author":"Mullighan","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.cyto.2015.12.025_b0010","first-page":"529","article-title":"Developmental gene networks: a triathlon on the course to T cell identity","volume":"14","author":"Yui","year":"2014","journal-title":"Nat. Rev."},{"key":"10.1016\/j.cyto.2015.12.025_b0015","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.1038\/onc.2012.347","article-title":"JAK\/STAT signaling in hematological malignancies","volume":"32","author":"Vainchenker","year":"2013","journal-title":"Oncogene"},{"key":"10.1016\/j.cyto.2015.12.025_b0020","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1038\/ng.924","article-title":"Oncogenic IL7R gain-of-function mutations in childhood T-cell acute lymphoblastic leukemia","volume":"43","author":"Zenatti","year":"2011","journal-title":"Nat. Genet."},{"key":"10.1016\/j.cyto.2015.12.025_b0025","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1084\/jem.20110580","article-title":"Gain-of-function mutations in interleukin-7 receptor-alpha (IL7R) in childhood acute lymphoblastic leukemias","volume":"208","author":"Shochat","year":"2011","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.cyto.2015.12.025_b0030","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1146\/annurev-med-051113-024537","article-title":"The JAK\u2013STAT pathway: impact on human disease and therapeutic intervention","volume":"66","author":"O\u2019Shea","year":"2015","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.cyto.2015.12.025_b0035","article-title":"Activating somatic mutations outside the SH2-domain of STAT3 in LGL leukemia","author":"Andersson","year":"2015","journal-title":"Leukemia"},{"key":"10.1016\/j.cyto.2015.12.025_b0040","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1038\/leu.2014.89","article-title":"Novel activating STAT5B mutations as putative drivers of T-cell acute lymphoblastic leukemia","volume":"28","author":"Kontro","year":"2014","journal-title":"Leukemia"},{"key":"10.1016\/j.cyto.2015.12.025_b0045","doi-asserted-by":"crossref","first-page":"e168","DOI":"10.1038\/bcj.2013.65","article-title":"Novel somatic mutations in large granular lymphocytic leukemia affecting the STAT-pathway and T-cell activation","volume":"3","author":"Andersson","year":"2013","journal-title":"Blood Cancer J."},{"key":"10.1016\/j.cyto.2015.12.025_b0050","doi-asserted-by":"crossref","first-page":"4541","DOI":"10.1182\/blood-2012-12-474577","article-title":"Discovery of somatic STAT5b mutations in large granular lymphocytic leukemia","volume":"121","author":"Rajala","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.cyto.2015.12.025_b0055","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1056\/NEJMoa1114885","article-title":"Somatic STAT3 mutations in large granular lymphocytic leukemia","volume":"366","author":"Koskela","year":"2012","journal-title":"New Engl. J. Med."},{"key":"10.1016\/j.cyto.2015.12.025_b0060","doi-asserted-by":"crossref","first-page":"2679","DOI":"10.1038\/sj.onc.1209151","article-title":"Mutations of the tumor suppressor gene SOCS-1 in classical Hodgkin lymphoma are frequent and associated with nuclear phospho-STAT5 accumulation","volume":"25","author":"Weniger","year":"2006","journal-title":"Oncogene"},{"key":"10.1016\/j.cyto.2015.12.025_b0065","doi-asserted-by":"crossref","first-page":"2535","DOI":"10.1182\/blood-2004-09-3701","article-title":"Biallelic mutation of SOCS-1 impairs JAK2 degradation and sustains phospho-JAK2 action in the MedB-1 mediastinal lymphoma line","volume":"105","author":"Melzner","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.cyto.2015.12.025_b0070","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1038\/sj.onc.1208032","article-title":"Differential methylation of genes that regulate cytokine signaling in lymphoid and hematopoietic tumors","volume":"24","author":"Reddy","year":"2005","journal-title":"Oncogene"},{"key":"10.1016\/j.cyto.2015.12.025_b0075","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1002\/hon.2010","article-title":"Alterations of negative regulators of cytokine signalling in immunodeficiency-related non-Hodgkin lymphoma","volume":"31","author":"Capello","year":"2013","journal-title":"Hematol. Oncol."},{"key":"10.1016\/j.cyto.2015.12.025_b0080","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/sj.leu.2403610","article-title":"Constitutive SOCS-3 expression protects T-cell lymphoma against growth inhibition by IFNalpha","volume":"19","author":"Brender","year":"2005","journal-title":"Leukemia"},{"key":"10.1016\/j.cyto.2015.12.025_b0085","doi-asserted-by":"crossref","first-page":"4","DOI":"10.2174\/187152012798764741","article-title":"Impact of oncogenic protein tyrosine phosphatases in cancer","volume":"12","author":"Hardy","year":"2012","journal-title":"Anti-Cancer Agents Med. Chem."},{"key":"10.1016\/j.cyto.2015.12.025_b0090","doi-asserted-by":"crossref","first-page":"7117","DOI":"10.1128\/MCB.21.21.7117-7136.2001","article-title":"Structural and evolutionary relationships among protein tyrosine phosphatase domains","volume":"21","author":"Andersen","year":"2001","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.cyto.2015.12.025_b0095","first-page":"287","article-title":"Reversible phosphorylation in haematological malignancies: potential role for protein tyrosine phosphatases in treatment?","volume":"1806","author":"Ruela-de-Sousa","year":"2010","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.cyto.2015.12.025_b0100","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1074\/mcp.M800196-MCP200","article-title":"Investigation of protein\u2013tyrosine phosphatase 1B function by quantitative proteomics","volume":"7","author":"Mertins","year":"2008","journal-title":"Mol. Cell. Proteomics: MCP"},{"key":"10.1016\/j.cyto.2015.12.025_b0105","doi-asserted-by":"crossref","first-page":"430","DOI":"10.3109\/10409238.2013.819830","article-title":"PTP1B: a simple enzyme for a complex world","volume":"48","author":"Feldhammer","year":"2013","journal-title":"Crit. Rev. Biochem. Mol. Biol."},{"key":"10.1016\/j.cyto.2015.12.025_b0110","doi-asserted-by":"crossref","first-page":"47771","DOI":"10.1074\/jbc.C100583200","article-title":"TYK2 and JAK2 are substrates of protein\u2013tyrosine phosphatase 1B","volume":"276","author":"Myers","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cyto.2015.12.025_b0115","doi-asserted-by":"crossref","first-page":"4098","DOI":"10.1182\/blood-2008-03-148726","article-title":"PTP1B is a negative regulator of interleukin 4-induced STAT6 signaling","volume":"112","author":"Lu","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.cyto.2015.12.025_b0120","doi-asserted-by":"crossref","first-page":"2776","DOI":"10.1073\/pnas.0508563103","article-title":"Protein tyrosine phosphatase 1B negatively regulates macrophage development through CSF-1 signaling","volume":"103","author":"Heinonen","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.cyto.2015.12.025_b0125","article-title":"Myeloid-cell protein tyrosine phosphatase-1B deficiency in mice protects against high-fat diet and lipopolysaccharide induced inflammation, hyperinsulinemia and endotoxemia through an IL10 STAT3 dependent mechanism","author":"Grant","year":"2013","journal-title":"Diabetes"},{"key":"10.1016\/j.cyto.2015.12.025_b0130","doi-asserted-by":"crossref","first-page":"ra43","DOI":"10.1126\/scisignal.2005020","article-title":"Protein tyrosine phosphatase 1B is a regulator of the interleukin-10-induced transcriptional program in macrophages","volume":"7","author":"Pike","year":"2014","journal-title":"Sci. Signal."},{"key":"10.1016\/j.cyto.2015.12.025_b0135","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1083\/jcb.117.2.401","article-title":"Expression of a protein tyrosine phosphatase in normal and v-src-transformed mouse 3T3 fibroblasts","volume":"117","author":"Woodford-Thomas","year":"1992","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.cyto.2015.12.025_b0140","first-page":"478","article-title":"Effect of protein tyrosine phosphatase 1B expression on transformation by the human neu oncogene","volume":"52","author":"Brown-Shimer","year":"1992","journal-title":"Cancer Res."},{"key":"10.1016\/j.cyto.2015.12.025_b0145","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.bbapap.2009.09.018","article-title":"The two faces of PTP1B in cancer","volume":"1804","author":"Lessard","year":"2010","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.cyto.2015.12.025_b0150","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/ng1963","article-title":"Protein tyrosine phosphatase 1B deficiency or inhibition delays ErbB2-induced mammary tumorigenesis and protects from lung metastasis","volume":"39","author":"Julien","year":"2007","journal-title":"Nat. Genet."},{"key":"10.1016\/j.cyto.2015.12.025_b0155","doi-asserted-by":"crossref","first-page":"10088","DOI":"10.1158\/0008-5472.CAN-05-1353","article-title":"Genetic ablation of protein tyrosine phosphatase 1B accelerates lymphomagenesis of p53-null mice through the regulation of B-cell development","volume":"65","author":"Dube","year":"2005","journal-title":"Cancer Res."},{"key":"10.1016\/j.cyto.2015.12.025_b0160","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/ng.2900","article-title":"Recurrent somatic mutations of PTPN1 in primary mediastinal B cell lymphoma and Hodgkin lymphoma","volume":"46","author":"Gunawardana","year":"2014","journal-title":"Nat. Genet."},{"key":"10.1016\/j.cyto.2015.12.025_b0165","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1080\/1042819031000068007","article-title":"IL-4 biology: impact on normal and leukemic CLL B cells","volume":"44","author":"Kay","year":"2003","journal-title":"Leukemia Lymphoma"},{"key":"10.1016\/j.cyto.2015.12.025_b0170","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1139\/y06-012","article-title":"PTP1B and TC-PTP: novel roles in immune-cell signaling","volume":"84","author":"Simoncic","year":"2006","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"10.1016\/j.cyto.2015.12.025_b0175","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.ymeth.2013.08.020","article-title":"Characterization of PTPN2 and its use as a biomarker","volume":"65","author":"Bussieres-Marmen","year":"2014","journal-title":"Methods (San Diego, Calif)"},{"key":"10.1016\/j.cyto.2015.12.025_b0180","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1128\/MCB.18.3.1622","article-title":"Epidermal growth factor receptor and the adaptor protein p52Shc are specific substrates of T-cell protein tyrosine phosphatase","volume":"18","author":"Tiganis","year":"1998","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.cyto.2015.12.025_b0185","doi-asserted-by":"crossref","first-page":"21548","DOI":"10.1074\/jbc.272.34.21548","article-title":"Association of the T-cell protein tyrosine phosphatase with nuclear import factor p97","volume":"272","author":"Tiganis","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cyto.2015.12.025_b0190","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1084\/jem.186.5.683","article-title":"Impaired bone marrow microenvironment and immune function in T cell protein tyrosine phosphatase-deficient mice","volume":"186","author":"You-Ten","year":"1997","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.cyto.2015.12.025_b0195","doi-asserted-by":"crossref","first-page":"3457","DOI":"10.1182\/blood-2003-09-3153","article-title":"T-cell protein tyrosine phosphatase deletion results in progressive systemic inflammatory disease","volume":"103","author":"Heinonen","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.cyto.2015.12.025_b0200","doi-asserted-by":"crossref","first-page":"4758","DOI":"10.1172\/JCI59492","article-title":"T cell protein tyrosine phosphatase attenuates T cell signaling to maintain tolerance in mice","volume":"121","author":"Wiede","year":"2011","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.cyto.2015.12.025_b0205","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1111\/j.1600-065X.2008.00743.x","article-title":"T-cell protein tyrosine phosphatase is a key regulator in immune cell signaling: lessons from the knockout mouse model and implications in human disease","volume":"228","author":"Doody","year":"2009","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.cyto.2015.12.025_b0210","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/S0960-9822(02)00697-8","article-title":"The T cell protein tyrosine phosphatase is a negative regulator of janus family kinases 1 and 3","volume":"12","author":"Simoncic","year":"2002","journal-title":"Curr. Biol."},{"key":"10.1016\/j.cyto.2015.12.025_b0215","doi-asserted-by":"crossref","first-page":"4220","DOI":"10.1182\/blood-2006-08-044370","article-title":"TC-PTP-deficient bone marrow stromal cells fail to support normal B lymphopoiesis due to abnormal secretion of interferon-{gamma}","volume":"109","author":"Bourdeau","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.cyto.2015.12.025_b0220","doi-asserted-by":"crossref","first-page":"3073","DOI":"10.1038\/ncomms4073","article-title":"PTPN2 attenuates T-cell lymphopenia-induced proliferation","volume":"5","author":"Wiede","year":"2014","journal-title":"Nat. Commun."},{"key":"10.1016\/j.cyto.2015.12.025_b0225","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1038\/ng.587","article-title":"Deletion of the protein tyrosine phosphatase gene PTPN2 in T-cell acute lymphoblastic leukemia","volume":"42","author":"Kleppe","year":"2010","journal-title":"Nat. Genet."},{"key":"10.1016\/j.cyto.2015.12.025_b0230","first-page":"380","article-title":"Molecular pathogenesis of T-cell leukaemia and lymphoma","volume":"8","author":"Aifantis","year":"2008","journal-title":"Nat. Rev."},{"key":"10.1016\/j.cyto.2015.12.025_b0235","doi-asserted-by":"crossref","first-page":"7090","DOI":"10.1182\/blood-2010-10-314286","article-title":"PTPN2 negatively regulates oncogenic JAK1 in T-cell acute lymphoblastic leukemia","volume":"117","author":"Kleppe","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.cyto.2015.12.025_b0240","doi-asserted-by":"crossref","first-page":"4173","DOI":"10.1182\/blood-2003-11-3944","article-title":"Age-related phenotypic and oncogenic differences in T-cell acute lymphoblastic leukemias may reflect thymic atrophy","volume":"104","author":"Asnafi","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.cyto.2015.12.025_b0245","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S1535-6108(02)00018-1","article-title":"Gene expression signatures define novel oncogenic pathways in T cell acute lymphoblastic leukemia","volume":"1","author":"Ferrando","year":"2002","journal-title":"Cancer Cell"},{"key":"10.1016\/j.cyto.2015.12.025_b0250","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1182\/blood-2004-10-3900","article-title":"HOXA genes are included in genetic and biologic networks defining human acute T-cell leukemia (T-ALL)","volume":"106","author":"Soulier","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.cyto.2015.12.025_b0255","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/S0140-6736(04)15542-6","article-title":"Prognostic importance of TLX1 (HOX11) oncogene expression in adults with T-cell acute lymphoblastic leukaemia","volume":"363","author":"Ferrando","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.cyto.2015.12.025_b0260","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1038\/sj.leu.2402892","article-title":"Expression of HOX11 in childhood T-lineage acute lymphoblastic leukaemia can occur in the absence of cytogenetic aberration at 10q24: a study from the Children\u2019s Cancer Group (CCG)","volume":"17","author":"Kees","year":"2003","journal-title":"Leukemia"},{"key":"10.1016\/j.cyto.2015.12.025_b0265","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1038\/sj.leu.2403061","article-title":"t(5;14)\/HOX11L2-positive T-cell acute lymphoblastic leukemia. A collaborative study of the Groupe Francais de Cytogenetique Hematologique (GFCH)","volume":"17","author":"Berger","year":"2003","journal-title":"Leukemia"},{"key":"10.1016\/j.cyto.2015.12.025_b0270","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1038\/368747a0","article-title":"Hox11 controls the genesis of the spleen","volume":"368","author":"Roberts","year":"1994","journal-title":"Nature"},{"key":"10.1016\/j.cyto.2015.12.025_b0275","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1038\/nm.2246","article-title":"The TLX1 oncogene drives aneuploidy in T cell transformation","volume":"16","author":"De Keersmaecker","year":"2010","journal-title":"Nat. Med."},{"key":"10.1016\/j.cyto.2015.12.025_b0280","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.3324\/haematol.2011.041921","article-title":"Mutation analysis of the tyrosine phosphatase PTPN2 in Hodgkin\u2019s lymphoma and T-cell non-Hodgkin\u2019s lymphoma","volume":"96","author":"Kleppe","year":"2011","journal-title":"Haematologica"},{"key":"10.1016\/j.cyto.2015.12.025_b0285","doi-asserted-by":"crossref","first-page":"5016","DOI":"10.1182\/blood-2008-12-196709","article-title":"TC-PTP is required for the maintenance of MYC-driven B-cell lymphomas","volume":"114","author":"Young","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.cyto.2015.12.025_b0290","doi-asserted-by":"crossref","first-page":"rs1","DOI":"10.1126\/scisignal.2000966","article-title":"Comprehensive expression profiles of genes for protein tyrosine phosphatases in immune cells","volume":"3","author":"Arimura","year":"2010","journal-title":"Sci. Signal."}],"container-title":["Cytokine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466615301381?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466615301381?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,15]],"date-time":"2018-09-15T20:54:50Z","timestamp":1537044890000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043466615301381"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6]]},"references-count":58,"alternative-id":["S1043466615301381"],"URL":"https:\/\/doi.org\/10.1016\/j.cyto.2015.12.025","relation":{},"ISSN":["1043-4666"],"issn-type":[{"value":"1043-4666","type":"print"}],"subject":[],"published":{"date-parts":[[2016,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"TC-PTP and PTP1B: Regulating JAK\u2013STAT signaling, controlling lymphoid malignancies","name":"articletitle","label":"Article Title"},{"value":"Cytokine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cyto.2015.12.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}